AstraZeneca and all the others: that’s when and why the benefits outweigh the risks

– Milena Gabanelli and Simona Ravizza /Courier TV
KEEP READING ”

After thrombosis cases across Europe, Ema reviewed the data on the AstraZeneca vaccine and concluded that the benefits outweigh the risks. Milena Gabanelli and Simona Ravizza discuss it with Guido Rasi, professor of Microbiology at the University of Tor Vergata and former Ema director. Read the investigation here